Prot #ML28726: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Assess the Efficacy and Safety of Oral Vismodegib for the Treatment of Basal cell Carcinoma Preceding Excision by Mohs Micrographic Surgery

Project: Research project

StatusFinished
Effective start/end date10/2/138/15/15

Funding

  • PPD Development (Prot #ML28726)
  • Genentech, Inc. (Prot #ML28726)